These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7940839)

  • 21. Renal impairment and diabetes mellitus after liver transplant.
    Sutedja DS; Wai CT; Teoh KF; Lee HL; DaCosta M; Lee M; Kaur M; Lee YM; Lee KH; Mak K; Quak SH; Isaac J; Lim SG; Prabhakaran K
    Transplant Proc; 2004 Oct; 36(8):2324-7. PubMed ID: 15561238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion from standard cyclosporine to low-dose cyclosporine in liver transplant recipients: effect on nephrotoxicity and hypertension beyond one year.
    Eid A; Perkins JD; Rakela J; Krom RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2238-9. PubMed ID: 2652725
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac transplantation with cyclosporine and steroids: medium and long-term results.
    Hakim M; Spiegelhalter D; English TA; Caine N; Wallwork J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):327-32. PubMed ID: 3291264
    [No Abstract]   [Full Text] [Related]  

  • 24. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
    Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
    Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
    Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Lohmann R; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation.
    Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM
    Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on liver transplantation using cyclosporine.
    Schrem H; Lück R; Becker T; Nashan B; Klempnauer J
    Transplant Proc; 2004 Nov; 36(9):2525-31. PubMed ID: 15621081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CyA-NOF for early oral CyA-based immunosuppression in patients after liver transplantation.
    Kattner A; Winkler M; Oldhafer K; Ringe B; Maibücher A; Pichlmayr R
    Transplant Proc; 1996 Apr; 28(2):900-5. PubMed ID: 8623454
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia.
    Raghavachar A; Ganser A; Freund M; Heimpel H; Herrmann F; Schrezenmeier H
    Cytokines Mol Ther; 1996 Dec; 2(4):215-23. PubMed ID: 9384707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
    Asante-Korang A; Boyle GJ; Webber SA; Miller SA; Fricker FJ
    J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic renal dysfunction late after liver transplantation.
    Cohen AJ; Stegall MD; Rosen CB; Wiesner RH; Leung N; Kremers WK; Zein NN
    Liver Transpl; 2002 Oct; 8(10):916-21. PubMed ID: 12360433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
    Hoitsma AJ; Hilbrands LB
    Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New-onset cardiovascular risk factors in lung transplant recipients.
    Silverborn M; Jeppsson A; Mårtensson G; Nilsson F
    J Heart Lung Transplant; 2005 Oct; 24(10):1536-43. PubMed ID: 16210127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal function in pediatric liver transplantation: a long-term follow-up study.
    Harambat J; Ranchin B; Dubourg L; Liutkus A; Hadj-Haïssa A; Rivet C; Boillot O; Lachaux A; Cochat P
    Transplantation; 2008 Oct; 86(8):1028-34. PubMed ID: 18946339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
    Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
    Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.